Atlas Trials

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

Clinical trial NCT02333565 · COMPLETED

Trial details

NCT number
NCT02333565
Sponsor
Assistance Publique Hopitaux De Marseille
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent MeningiomasResistant Meningiomas
Start date
2015-01-22
Primary completion
2019-01-21
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.